A cohort event monitoring study to characterise use of eplontersen in patients with prior liver transplant and pre-existing severe hepatic impairment and to assess long-term safety among all new users of eplontersen (sTTRing)

05/01/2026
19/11/2026
EU PAS number:
EUPAS1000000890
Study
Ongoing
Documents
Study protocol
Initial protocol
English (865.35 KB - PDF) View document
Study results
No information provided.
Study report
Study report
English (5.59 MB - PDF) View document
ENCePP Seal
No information provided.